Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Marks

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Journal of the National Cancer Institute|December 12, 1992
Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivationI J Jacobs, M F Kohler, R W Wiseman, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1996
Tissue transglutaminase expression in human breast cancerJ M Hettasch, N Bandarenko, J L Burchette, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1996
BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cellsJ P Vaughn, P L Davis, M D Jarboe, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2000
High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancerA T Ferguson, E Evron, C B Umbricht, et al.
Cancer Research|June 1, 1991
Overexpression and mutation of p53 in epithelial ovarian cancerJ R Marks, A M Davidoff, B J Kerns, et al.
Cancer Research|March 25, 1992
Overexpression and mutation of p53 in endometrial carcinomaM F Kohler, A Berchuck, A M Davidoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Frequency of germline and somatic BRCA1 mutations in ovarian cancerA Berchuck, K A Heron, M E Carney, et al.
Oncogene|October 7, 2008
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cellsT Baba, P A Convery, N Matsumura, et al.
Cancer Research|January 13, 2001
Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancerP Seth, K L Lunetta, D W Bell, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2001
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cellsI E Krop, D Sgroi, D A Porter, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|December 12, 1992
Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivationI J Jacobs, M F Kohler, R W Wiseman, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1996
Tissue transglutaminase expression in human breast cancerJ M Hettasch, N Bandarenko, J L Burchette, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1996
BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cellsJ P Vaughn, P L Davis, M D Jarboe, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2000
High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancerA T Ferguson, E Evron, C B Umbricht, et al.
Cancer Research|June 1, 1991
Overexpression and mutation of p53 in epithelial ovarian cancerJ R Marks, A M Davidoff, B J Kerns, et al.
Cancer Research|March 25, 1992
Overexpression and mutation of p53 in endometrial carcinomaM F Kohler, A Berchuck, A M Davidoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Frequency of germline and somatic BRCA1 mutations in ovarian cancerA Berchuck, K A Heron, M E Carney, et al.
Oncogene|October 7, 2008
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cellsT Baba, P A Convery, N Matsumura, et al.
Cancer Research|January 13, 2001
Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancerP Seth, K L Lunetta, D W Bell, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2001
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cellsI E Krop, D Sgroi, D A Porter, et al.
Pageof 8